Nature Communications · 2019 · 105 citations · 26 references
Life SciencesImmunologyPharmacologyImmunoregulationImmunotherapyTransplant ImmunologyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint RegulationImmunosuppressionImmunosuppressive TherapyMtor Inhibitor TherapyImmunologic Response To AllograftInhibitory Checkpoint SignalingMtor InhibitionMtor SignalingPeripheral EosinophiliaProgrammed Death 1 SignalingProgrammed Death-1 BlockadeProgrammed Death-1 Inhibition
Abstract Immune checkpoint inhibitor (ICI) use remains a challenge in patients with solid organ allografts as most would undergo rejection. In a melanoma patient in whom programmed-death 1 (PD-1) blockade resulted in organ rejection and colitis, the addition of the mTOR inhibitor sirolimus resulted in ongoing anti-tumor efficacy while promoting allograft tolerance. Strong granzyme B + , interferon (IFN)-γ + CD8 + cytotoxic T cell and circulating regulatory T (T reg ) cell responses were noted during allograft rejection, along with significant eosinophilia and elevated serum IL-5 and eotaxin levels. Co-treatment with sirolimus abated cytotoxic T cell numbers and eosinophilia, while elevated T reg cell numbers in the peripheral blood were maintained. Interestingly, numbers of IFN-γ + CD4 + T cells and serum IFN-γ levels increased with the addition of sirolimus treatment likely promoting ongoing anti-PD-1 efficacy. Thus, our results indicate that sirolimus has the potential to uncouple anti-PD-1 therapy toxicity and efficacy.
26
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Jason D. Fontenot, Jeffrey P. Rasmussen, Marc A. Gavin et al. · Nature Immunology · 2005 · 1.8K citations
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Greg M. Delgoffe, Thomas P. Kole, Yan Zheng et al. · Immunity · 2009 · 1.3K citations · Full text
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth et al. · Nature · 2015 · 1.2K citations · Full text
Medicine, Immunology, Oncology +17
Karline Guilloteau, Isabelle Pâris, Nathalie Pedretti et al. · The Journal of Immunology · 2010 · 346 citations · Full text
Medicine, Dermatology, Immunology +17